Osteoporosis
Merrion reports positive clinical results for alendronate sodium drug
Published in Healthcare Mergers, Acquisitions and Ventures Week, February 17th, 2007
MER 103 is an enteric-coated tablet of alendronate and GIPET, Merrion's proprietary platform technology, which increases drug absorption. The study confirmed several important improvements for patient convenience and compliance relating to the administration of alendronate, the leading bisphosphonate for the prevention and treatment of osteoporosis, marketed as Fosamax (Merck).
The study was conducted in postmenopausal women and compared the absorption of a 6...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Acromegaly
Tercica reports NDA for Somatuline Autogel for acromegaly accepted for filing by U.S. FDA - Allergies Therapy
Study results from Syngenta broaden understanding of allergies therapy - Alzheimer Disease
Howard Hughes Medical Institute scientists discover new genetic risk factor for Alzheimer - Alzheimer Disease
New gene uncovered for Alzheimer disease - Angiology
ProRhythm initiates U.S. pivotal trial for HIFU ablation system - Antipsychotics
Evidence lacking to support many off-label uses of atypical antipsychotics - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
